31 May 2024
Assura plc
Annual Report & Notice of
AGM
Assura plc ("Assura"), the
specialist healthcare property investor and developer, is pleased
to announce that the Annual General Meeting ("AGM") will be held on
Thursday 4 July 2024 at 11am BST.
The Annual Report and Accounts for
the year ended 31 March 2024 and the Notice of AGM will be posted
to shareholders today.
In accordance with Listing Rule
9.6.1, copies of these documents have also been submitted to the UK
Listing Authority via the National Storage Mechanism and will be
available for viewing shortly at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
and can also be found on the Company's website
at
http://assuraplc.com/investor-relations/reports-and-presentations/.
Shareholders will be able to watch
the AGM over the online Investor Meet Company platform by
registering in advance via the following link:
https://www.investormeetcompany.com/assura-plc/register-investor
Shareholders are invited to submit
any questions in respect of the business of the AGM for the Board
to consider. Questions may be submitted in advance over the
Investor Meet Company platform following registration and the Board
will aim to respond to any such questions relevant to the business
of the AGM. Further information is set out in the Notice of
AGM.
Shareholders wishing to vote at the
AGM are strongly encouraged to do so by completing a Form of Proxy
as appropriate. Shareholders will
not be able to vote at the meeting over the online
platform.
- Ends
-
For more information, please
contact:
|
Assura plc
David Purcell, Investor Relations
Director
|
Tel: 0161 515
2043
Email: Investor@assura.co.uk
|
|
Finsbury Glover Hering
Gordon Simpson
|
Tel: 0207 251 3801
Email: Assura@fgsglobal.com
|
Notes to Editors
Assura plc is the UK's leading
specialist healthcare property investor and developer. Assura
enables better health outcomes through its portfolio of more than
600 healthcare buildings, from which over six million patients are
served.
A UK REIT based in Altrincham,
Assura is a constituent of the FTSE 250 and the EPRA* indices. As
at 31 March 2024, Assura's portfolio was valued at £2.7 billion and
has a strong track record of growing financial returns and
dividends for shareholders.
At Assura, we BUILD for health,
having developed over 100 new healthcare buildings in our history,
and at the heart of our strategy sits The Bigger Picture; Healthy
Environment (E), Healthy Communities (S), Healthy Business
(G).
Further information is available
at www.assuraplc.com
*EPRA is a
registered trademark of the European Public Real Estate
Association